close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
99 100 Next >
Intuitive Surgical's Stellar Q2 2025 Performance Propels Robotic Surgery Market Forward
Via MarketMinute
Topics Artificial Intelligence Supply Chain
Tickers ISRG JNJ MDT SYK ZBH
Exposures Artificial Intelligence Product Safety Supply Chain
Why Roivant Sciences Stock Is Soaring Today
Via The Motley Fool
Tickers ROIV
Exposures Product Safety
Roivant Leaps Into A Profit-Taking Zone, Stoked By Promise In Autoimmune Disease
Via Investor's Business Daily
Tickers AAPL ROIV
Exposures Product Safety
Oruka Therapeutics, Up 20%, Is Trying To Take On AbbVie's Biggest Moneymaker
Via Investor's Business Daily
Tickers AAPL ABBV ORKA
Exposures Product Safety
US FDA Alleges Novo Nordisk’s Video On Weight-loss Drugs Featuring Oprah Winfrey Is ‘False Or Misleading’
Via Stocktwits
Tickers DFAX NDVG NVO
Exposures Product Safety
Levi & Korsinsky Notifies Replimune Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 7, 2025 - SVRA
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Notifies Replimune Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 7, 2025 - SVRA
Via NewMediaWire
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
Shareholders That Lost Money on Unicycive Therapeutics, Inc. (UNCY) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Via NewMediaWire
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Shareholders That Lost Money on Unicycive Therapeutics, Inc. (UNCY) Urged to Join Class Action - Contact Levi &amp; Korsinsky to Learn More
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Where Will Rivian Be in 2028, and Is It a Buy Now?
Via The Motley Fool
Topics Electric Vehicles Product Recall World Trade
Tickers F RIVN
Exposures Electric Vehicles Legal Product Safety
Rezolute Stock: FDA Fast Track Fuels 2025 Breakout
Via MarketBeat
Tickers RZLT
Exposures Product Safety
2 High-Yield Dividend Stocks You'll Wish You Had Bought 10 Years From Now
Via The Motley Fool
Tickers HIMS NVO TXN
Exposures Product Safety
Rise Health Nano Optics Achieves FDA Clearance Milestone Following Successful Biocompatibility Testing for EYEGUARD Lenses
Via Newsfile
Exposures Product Safety
World Suicide Prevention Efforts Urge Parents to Heal Themselves First
Via 24-7 Press Release
Topics Product Recall
Exposures COVID-19 Legal Product Safety
1 Healthcare Stock Worth Your Attention and 2 We Brush Off
Via StockStory
Topics Stocks
Tickers DXCM EHC XRAY
Exposures COVID-19 Product Safety US Equities
Wall Street Waits on the Fed, but Steel and Semaglutide Steal the Show
Via Chartmill
Topics Economy
Tickers CMG GOOG HIMS NYT PLAY STLD
Exposures Interest Rates Product Safety
Why Eli Lilly Stock Was a Winner Today
Via The Motley Fool
Tickers LLY
Exposures Product Safety
Dr. Jason Brinton Selected as Principal Investigator for Landmark FDA Study Demonstrating Superior Safety and Efficacy of EVO ICL Technology
Via Press Advantage
Exposures Product Safety
Stuart Deane Urges Communities to Slow Down, Listen More, and Reconnect With What Matters
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Aptevo Therapeutics Stock Rallies On 100% Remission Rate In Acute Myeloid Leukemia Trial Cohort
Via Stocktwits
Tickers APVO
Exposures Product Safety
Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why
Via StockStory
Tickers HIMS
Exposures Product Safety
Novo Nordisk Navigates a GLP-1 Gold Rush: Soaring Obesity Drug Sales Clash with Revised Outlook Amidst Mounting Competition
Via MarketMinute
Topics Earnings Economy Intellectual Property
Tickers CTLT LLY NVO
Exposures Financial Intellectual Property Product Safety
FDA Flags Eli Lilly's Weight-Loss Drug Video For Misleading Claims
Via Benzinga
Tickers LLY
Exposures Product Safety
Hims & Hers Scrutinized For Marketing Its Product As Similar To Ozempic, Wegovy
Via Benzinga
Tickers HIMS NVO
Exposures Product Safety
FDA Slams Hims & Hers With A Warning Letter. Investors Slam Hims Stock.
Via Investor's Business Daily
Tickers HIMS
Exposures Product Safety
Wegovy's Next Step: Novo Nordisk Eyes Approval for Higher-Dose Treatment
Via Benzinga
Tickers LLY NVO
Exposures Product Safety
Shareholders That Lost Money on Unicycive Therapeutics, Inc. (UNCY) Should Contact Levi & Korsinsky About Pending Class Action - UNCY
Via NewMediaWire
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Savara Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before November 7, 2025 to Discuss Your Rights - SVRA
Via NewMediaWire
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today